Empagliflozin and Erythropoiesis in Peritoneal Dialysis: A Prespecified Secondary Analysis of the EMPOWERED Trial. // Kidney Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S2590059526003535?dgcid=rss_sd_all
Empagliflozin and Erythropoiesis in Peritoneal Dialysis: A Prespecified Secondary Analysis of the EMPOWERED Trial. Kidney Medicine. https://www.sciencedirect.com/science/article/pii/S2590059526003535?dgcid=rss_sd_all
“Empagliflozin and Erythropoiesis in Peritoneal Dialysis: A Prespecified Secondary Analysis of the EMPOWERED Trial.” Kidney Medicine.
@article{article117335,
title = {Empagliflozin and Erythropoiesis in Peritoneal Dialysis: A Prespecified Secondary Analysis of the EMPOWERED Trial},
journal = {Kidney Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S2590059526003535?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...